Search research articles
Contact Us
Filters
Showing results (61-70 of 114) with videos related to
Page
of 12
Sort By:
Expert Review of Gastroenterology & Hepatology
|
May 29, 2019
Considerations of heterogeneity in clinical trials for hepatocellular carcinoma
Tsung-Hao Liu, Yu-Yun Shao, Li-Chun Lu, et al.
Heliyon
|
August 5, 2024
Cyclin dependent kinase 9 inhibition reduced programmed death-ligand 1 expression and improved treatment efficacy in hepatocellular carcinoma
Yu-Yun Shao, Min-Shu Hsieh, Yi-Hsuan Lee, et al.
Anticancer Research
|
November 24, 2011
Impact of baseline hepatitis B viral DNA levels on survival of patients with advanced hepatocellular carcinoma
Yu-Yun Shao, Pei-Jer Chen, Zhong-Zhe Lin, et al.
Journal of Hepatology
|
September 17, 2013
Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapy
Yu-Yun Shao, Chih-Horng Wu, Li-Chun Lu, et al.
BMC Cancer
|
May 26, 2016
Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: a nationwide cohort study
Kuo-Hsing Chen, Yu-Yun Shao, Ho-Min Chen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 6, 2016
Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer
Yi-Hsin Liang, Chih-Hsin Wei, Wen-Hui Hsu, et al.
Thoracic Cancer
|
June 21, 2023
Different immune contextures underlie tumor site-specific responses to immune checkpoint blockade in esophageal cancer
Jhe-Cyuan Guo, Chia-Lang Hsu, Min-Shu Hsieh, et al.
Cancers
|
October 13, 2021
Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials
Bang-Bin Chen, Zhong-Zhe Lin, Yu-Yun Shao, et al.
Diagnostics (Basel, Switzerland)
|
August 27, 2021
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
Bang-Bin Chen, Yu-Yun Shao, Zhong-Zhe Lin, et al.
Anticancer Research
|
May 7, 2017
Prescription Patterns of Sorafenib and Outcomes of Patients with Advanced Hepatocellular Carcinoma: A National Population Study
Li-Chun Lu, Pei-Jer Chen, Yi-Chun Yeh, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 114) with videos related to
Sort By:
Page
of 12
Expert Review of Gastroenterology & Hepatology
|
May 29, 2019
Considerations of heterogeneity in clinical trials for hepatocellular carcinoma
Tsung-Hao Liu, Yu-Yun Shao, Li-Chun Lu, et al.
Heliyon
|
August 5, 2024
Cyclin dependent kinase 9 inhibition reduced programmed death-ligand 1 expression and improved treatment efficacy in hepatocellular carcinoma
Yu-Yun Shao, Min-Shu Hsieh, Yi-Hsuan Lee, et al.
Anticancer Research
|
November 24, 2011
Impact of baseline hepatitis B viral DNA levels on survival of patients with advanced hepatocellular carcinoma
Yu-Yun Shao, Pei-Jer Chen, Zhong-Zhe Lin, et al.
Journal of Hepatology
|
September 17, 2013
Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapy
Yu-Yun Shao, Chih-Horng Wu, Li-Chun Lu, et al.
BMC Cancer
|
May 26, 2016
Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: a nationwide cohort study
Kuo-Hsing Chen, Yu-Yun Shao, Ho-Min Chen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 6, 2016
Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer
Yi-Hsin Liang, Chih-Hsin Wei, Wen-Hui Hsu, et al.
Thoracic Cancer
|
June 21, 2023
Different immune contextures underlie tumor site-specific responses to immune checkpoint blockade in esophageal cancer
Jhe-Cyuan Guo, Chia-Lang Hsu, Min-Shu Hsieh, et al.
Cancers
|
October 13, 2021
Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials
Bang-Bin Chen, Zhong-Zhe Lin, Yu-Yun Shao, et al.
Diagnostics (Basel, Switzerland)
|
August 27, 2021
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
Bang-Bin Chen, Yu-Yun Shao, Zhong-Zhe Lin, et al.
Anticancer Research
|
May 7, 2017
Prescription Patterns of Sorafenib and Outcomes of Patients with Advanced Hepatocellular Carcinoma: A National Population Study
Li-Chun Lu, Pei-Jer Chen, Yi-Chun Yeh, et al.
Page
of 12